vitalityDNA plans to keep healthy indviduals healthy

May 18, 2017 Christoph Graener

Precision medicines, an increased interest in the microbiome and a growing focus on wellness are some of the latest trends gripping the healthcare industry. London-based startup vitalityDNA is combining all three to provide customers with personalized health and lifestyle plans. Founder and CEO Karolis Rosickas explained to Scrip’s Mike Ward how the two-year-old company is executing its business plan.

Interviewer: Mike Ward – Global Director of Content, Informa Pharma Insights
Interviewee: Karolis Rosickas – Founder and CEO, vitalityDNA

Previous Article
Mitochondrial medicine focus drives NeuroVive orphan ambitions

Underpinned by a profound understanding of genetic mitochondrial disorders, Swedish biotech NeuroVive Pharm...

Next Article
Producing monoclonals for at least a tenth of the cost

Dutch antibody technology company BiosanaPharma is offering to make monoclonal antibodies at between 5% and...